We report a patient who developed persistent nephrogenic diabetes insipidus associated with renal tubular acidosis, renal resistance to parathyroid hormone, aminoaciduria and proximal tubule pattern proteinuria in the presence of a reduced glomerular filtration rate (19-24 ml/min). A review ofthe previous reports of persistent nephrogenic diabetes insipidus revealed that in all patients the glomerular filtration rate had been less than 60 ml/min at presentation. Chronic renal failure may therefore predispose to the development of persistent nephrogenic diabetes insipidus in patients receiving lithium.
Introduction
Lithium salts, which are an established treatment of bipolar and some recurrent unipolar affective disorders, have a narrow therapeutic range which makes therapeutic monitoring mandatory.' 3 Lithium administration has become a common cause of nephrogenic diabetes insipidus. [4] [5] [6] [7] In a few patients nephrogenic diabetes insipidus has persisted following the withdrawal of lithium.8"-Reduction of glomerular filtration rate has also been attributed to chronic lithium administration although the evidence for this is weak.7"2 In addition, renal tubular acidosis and tubular proteinuria have also been attributed to chronic lithium administration.5'73',5 We report a patient who developed persistent nephrogenic diabetes insipidus accompanied by chronic renal failure with a renal tubular acidosis and aminoaciduria. We discuss the aetiology of the persistent nephrogenic diabetes insipidus and the other abnormalities of renal tubular function.
Clinical presentation
A 54 year old female with a 33 year history of a bipolar affective illness was referred with a history of 6 weeks of thirst, polyuria, lethargy and a weight loss of 5 kg. Her past medical history included two paracetamol overdoses 4 and 8 years prior to her presentation. Lithium, prescribed under inpatient supervision for 13 of the preceding 16 years, had been stopped 2 weeks after development of thirst and polyuria. Lofepramine, chlorpromazine and orphenadrine were prescribed at the time ofpresentation.
On examination she was thin, dehydrated, had a flattened affect and psychomotor retardation. Her blood pressure was 122/78 mmHg. The sodium concentration in her serum was 175 mmol/l consistent with hypernatraemic dehydration. Serum and urine osmolalities were 355 mosmol/kg and 129 mosmol/kg respectively.
Examination of fluid balance charts from 3 weeks prior to the development of hypernatraemia showed that she had been polyuric, passing more than 3 litres of urine each day, during the 3 days on which these charts had been kept. Despite unrestricted access to water and complaints of thirst she had been unable to maintain fluid balance.
Initial rehydration was with intravenous 5% dextrose. The sodium concentration in her serum fell to 152 mmol/l within 2 days. Intravenous fluids were discontinued and she was encouraged to take fluids by mouth. Possibly due to a reduced thirst sensation and psychomotor retardation her oral fluid intake was around 2.6 litres/day. Her serum sodium concentration rose over the next 3 days to 182 mmol/l. Intravenous fluids were recommenced with 4 litres of 5% dextrose daily. Following intravenous rehydration and the discontinuation of lofepramine and chlorpromazine her affect and sensation of thirst improved. Her oral fluid intake rose to 4.1-5 litres/day.
Investigation
The concentration of lithium in her serum 4 weeks prior to the development of hypernatraemia was 0.81 mmol/l. Lithium administration had been stopped at this time and lithium was not detected in her serum when she presented with hypernatraemia. Over the 13 years preceding the development of nephrogenic diabetes insipidus lithium had been measured on 74 occasions. The lithium concentrations had ranged from 0.53 to 2.4 mmol/l, 11 results were greater than 1.3 mmol/l and 7 were less than 0.7 mmol/l. Acute lithium toxicity had not occurred on any occasion.
To confirm the diagnosis of nephrogenic diabetes insipidus and assess the maximum urine concentration which could be achieved, a water deprivation test was undertaken. Water deprivation was commenced at 22 .00 h and continued until 17.00 h the next day. The results in Figure 1 showed that despite a raised basal arginine-vasopressin (AVP) concentration after overnight water deprivation, and an increase in plasma AVP concentration and serum osmolality during the test, no significant change in urine osmolality occurred. An intravenous injection of 2 jig of DDAVP was given at 17.00 h, indicated by an arrow on Figure 1 . Only a slight increase in the osmolality of the final urine sample passed that day was observed following this.
As her serum bicarbonate concentration had been persistently low, median 18 mmol/I (range [14] [15] [16] [17] [18] [19] [20] [21] [22] mmol/l), and random urine pH measurements were consistently greater than 6.0, an acid load test was undertaken. The results of this ( Figure 2 ) were compatible with a renal tubular acidosis. Her glomerular filtration rate as assessed by 4 consecutive creatinine clearances over a 4-week period was reduced (19 -24 ml/min). The 24-hour urine volumes were all greater than 3 litres, She returned to a psychiatric ward 2 months after transfer for investigation. She died I year later of bronchopneumonia, and as indicated above, autopsy showed endstage interstitial nephritis.
Discussion
Despite complaining of thirst and having free access to water our patient was unable to maintain an adequate fluid intake prior to treatment, perhaps suggesting that she had a reduced thirst sensation. The thirst mechanism has been found to be intact in patients with cranial diabetes insipidus,'7 although decreased thirst sensation in association with lithium-induced nephrogenic diabetes insipidus has been reported.'8 However, when her affect improved following withdrawal of chlorpromazine and lofepramine, and rehydration she maintained an adequate fluid intake and when treated exhibited a tendency to compulsive water drinking. This suggests that her initial failure to maintain an adequate fluid intake may have been due to a flattened affect and psychomotor retardation.
The mechanism by which lithium causes failure ofwater reabsorption in the distal tubule is thought to be the impairment of AVP-sensitive adenyl cyclase activity associated with cell membranes.7" '9 This enzyme generates intracellular cAMP which acts as the second messenger for AVP and PTH. Cellular uptake of lithium is thought to be necessary for its inhibitory effect on tubular water reabsorption.20'2 The intracellular mechanism by which lithium inactivates adenyl cyclase activity, and how this may persist following withdrawal of lithium is not known.
Cellular uptake of lithium is not required for the development of a urinary defect of hydrogen ion excretion.7 The persistence of this abnormality was consistent with persistent renal structural changes.22 '23 It has been suggested that lithiuminduced nephrogenic diabetes insipidus may be associated with tubular cytoplasmic swelling, glycogen deposition, dilation oftubules and microcyst formation.24'25 These histological changes are reversible but the renal biopsy findings from one patient with persistent nephrogenic diabetes insipidus were consistent with chronic interstitial nephritis.8 Experimental work has also suggested that chronic tubulo-interstitial changes may occur following long-term treatment with lithium.23
At post-mortem examination our patient had an endstage interstitial nephritis. The aminoaciduria, proteinuria, failure of urinary acidification, and renal PTH resistance may, therefore have occurred due to the development of an interstitial nephritis which could have been triggered by lithium administration.
The glomerular filtration rate was found to be less than 70 ml/min in only 15% of patients on long-term lithium.7 However, in 4 previous reports of persistent nephrogenic diabetes insipidus a reduced creatinine clearance was found, 35-60 ml/min.81-' Patients with severe chronic renal failure, GFR less than 14 ml/min, may also develop failure of the urinary concentrating mechanisms, including renal insensitivity to AVP, resulting in the production of hypotonic urine. 26 In addition, patients at risk ofdeveloping polyuria are those with higher therapeutic serum concentrations of lithium.27 As lithium is excreted by the kidney, patients with renal failure may be at risk of higher serum concentrations and greater intracellular accumulation of lithium than those with normal renal function. A reduced glomerular filtration rate may therefore predispose to the development of persistent nephrogenic diabetes insipidus in patients prescribed lithium.
In summary, close monitoring of the GFR of patients treated with lithium may be necessary because a reduced glomerular filtration rate was observed in our patient and in the previous reports of persistent nephrogenic diabetes insipidus.
